Outcomes Superior With CABG Versus Multivessel PCI
THURSDAY, Jan. 26, 2023 -- Coronary artery bypass grafting (CABG) outcomes are better than multivessel percutaneous coronary intervention (PCI) outcomes for patients with acute coronary syndrome, according to a study presented at the annual meeting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2023 Category: Pharmaceuticals Source Type: news

Black Patients Have Worse Percutaneous Coronary Intervention Outcomes
FRIDAY, Dec. 9, 2022 -- Black patients have a higher risk for 90-day readmission and mortality following percutaneous coronary intervention (PCI) than White patients, according to a study published online Nov. 11 in the American Heart... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2022 Category: Pharmaceuticals Source Type: news

Novel PCI Screening Approach Detects Diffuse CAD Novel PCI Screening Approach Detects Diffuse CAD
Pullback pressure gradient pre-percutaneous coronary intervention can differentiate diffuse and focal coronary artery disease.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2022 Category: Consumer Health News Tags: Cardiology News Source Type: news

Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI
(MedPage Today) -- CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with heparin in the BRIGHT... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 7, 2022 Category: Cardiology Source Type: news

Johnson & Johnson to Acquire Abiomed
New Brunswick, N.J. and Danvers, Mass., November 1, 2022 – Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion which includes cash acquired. Abiomed shareholders will also receive...
Source: Johnson and Johnson - November 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Long-Term Outcomes of PCI, CABG Compared for Multivessel CAD
WEDNESDAY, Oct. 5, 2022 -- For patients with multivessel coronary artery disease, the rates of major adverse cardiac events and safety events do not differ for those receiving percutaneous coronary intervention (PCI) with everolimus-eluting stent or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2022 Category: Pharmaceuticals Source Type: news

PCI vs CABG: Does Age Inform Choice for Left Main Coronary Artery Disease?
(MedPage Today) -- BOSTON -- Adding fuel to the controversy of revascularization for left main disease, patients had better survival after coronary artery bypass grafting (CABG) surgery than percutaneous coronary intervention (PCI) in an all... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - September 19, 2022 Category: Surgery Source Type: news

PCI Not (Much) Worse Than CABG for Multivessel Disease Long Term
(MedPage Today) -- BOSTON -- For multivessel coronary artery disease, percutaneous coronary intervention (PCI) pulled even, statistically speaking, with surgery for outcomes after a median of nearly 12 years of follow-up in the Korean BEST trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 19, 2022 Category: Cardiology Source Type: news

Fractional Flow Reserve Noninferior to IVUS for Guiding PCI
THURSDAY, Sept. 1, 2022 -- For patients with intermediate coronary stenosis being evaluated for percutaneous coronary intervention (PCI), fractional flow reserve (FFR) guidance is noninferior to intravascular ultrasonography (IVUS) guidance for a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 1, 2022 Category: Pharmaceuticals Source Type: news

Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet
(MedPage Today) -- BARCELONA -- For coronary angiography with or without percutaneous coronary intervention (PCI), radial access bested femoral access not only for reduced bleeding, but mortality as well, according to a meta-analysis by the Radial... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - August 29, 2022 Category: Urology & Nephrology Source Type: news

PCI Flops for Ischemic LV Dysfunction With Coronary Artery Disease
(MedPage Today) -- BARCELONA -- Percutaneous coronary intervention (PCI) did not improve outcomes for ischemic cardiomyopathy patients with substantial atherosclerotic coronary artery disease in the first few years after the procedure, the REVIVED... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 27, 2022 Category: Cardiology Source Type: news

Racial, Ethnic Disparities Seen in Management of NSTEMI
MONDAY, Aug. 8, 2022 -- In 2017 to 2019, Black and Hispanic individuals were less likely than Whites to undergo coronary angiography and percutaneous coronary intervention for non-ST-segment elevation myocardial infarction, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 8, 2022 Category: Pharmaceuticals Source Type: news

CTO PCI Success Rates Rising, Registry Shows CTO PCI Success Rates Rising, Registry Shows
Updated results from a registry of chronic total occlusion percutaneous coronary angioplasty cases reports improving outcomes over the past 6 years.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 9, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Abbott recalls Dragonfly OpStar Imaging Catheter
Abbott Medical has recalled its Dragonfly OpStar Imaging Catheter because potentia...Read more on AuntMinnie.comRelated Reading: Abbott expands MRI compatibility for Proclaim Abbott recalls 2 coronary angioplasty catheters FDA clears Abbott's ICD for use with MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 26, 2022 Category: Radiology Source Type: news

Chronic Total Occlusion PCI Is Getting Safer -- At Least Until the Pandemic
(MedPage Today) -- ATLANTA -- Percutaneous coronary intervention for chronic total occlusion (CTO PCI) has improved in success rates, but the pandemic might have impacted complication rates, a registry study showed. Technical and procedural... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 21, 2022 Category: Cardiology Source Type: news